Proteomics Market

1. Executive Summary
    1.1. Key Market Insights  

2. Introduction            
    2.1. Study Objectives        
    2.2. Market Definition        
           2.2.1. Market Covered    
           2.2.2. Regional Coverage    
           2.2.3. Study Years & Currency    
    2.3. Market Stakeholders        
    2.4. Key Questions this Study will Answer        
    2.5. GMI Research’s Approach & Methodology  
           2.5.1. Research Data
           2.5.2. Primary Data
           2.5.3. Demand Side and Supply Side Analysis
           2.5.4. Market Size Estimation
           2.5.5. Research Assumptions

3. Global Proteomics Market- Overview            
    3.1. Introduction         
    3.2. Market Segmentation        
    3.3. Value Chain Analysis        
    3.4. Market Drivers        
    3.5. Market Restraints        
    3.6. Market Trends      

4. Global Proteomics Market Revenue Forecast till 2027     

5. Global Proteomics Market by Product Revenue Forecast till 2027            
    5.1. Instruments
    5.2. Reagents
    5.3. Services

6. Global Proteomics Market by Technology Revenue Forecast till 2027            
    6.1. Microarray
    6.2. X-Ray Crystallography
    6.3. Spectroscopy
    6.4. Chromatography
    6.5. Protein Fractionation Systems
    6.6. Electrophoresis
    6.7. Surface Plasma Resonance Systems

7. Global Proteomics Market by Application Revenue Forecast till 2027            
    7.1. Drug Discovery
    7.2. Disease Diagnosis
    7.3. Others

8. Global Proteomics Market by Region Forecast till 2027
    8.1. North America Proteomics Market Revenue Forecast till 2027 
    (Option 1: As a part of the free 25% customization)
           8.1.1. North America Proteomics Market by Product
                     8.1.1.1. Instruments
                     8.1.1.2. Reagents
                     8.1.1.3. Services
           8.1.2. North America Proteomics Market by Technology
                     8.1.2.1. Microarray
                     8.1.2.2. X-Ray Crystallography
                     8.1.2.3. Spectroscopy
                     8.1.2.4. Chromatography
                     8.1.2.5. Protein Fractionation Systems
                     8.1.2.6. Electrophoresis
                     8.1.2.7. Surface Plasma Resonance Systems
           8.1.3. North America Proteomics Market by Application
                     8.1.3.1. Drug Discovery
                     8.1.3.2. Disease Diagnosis
                     8.1.3.3. Others
           8.1.4. US Proteomics Market All-Up
           8.1.5. Canada Proteomics Market All-Up
    8.2. Europe Proteomics Market Revenue Forecast till 2027 
    (Option 2: As a part of the free 25% customization)
           8.2.1. Europe Proteomics Market by Product
                     8.2.1.1. Instruments
                     8.2.1.2. Reagents
                     8.2.1.3. Services
           8.2.2. Europe Proteomics Market by Technology
                     8.2.2.1. Microarray
                     8.2.2.2. X-Ray Crystallography
                     8.2.2.3. Spectroscopy
                     8.2.2.4. Chromatography
                     8.2.2.5. Protein Fractionation Systems
                     8.2.2.6. Electrophoresis
                     8.2.2.7. Surface Plasma Resonance Systems
           8.2.3. Europe Proteomics Market by Application
                     8.2.3.1. Drug Discovery
                     8.2.3.2. Disease Diagnosis
                     8.2.3.3. Others
           8.2.4. UK Proteomics Market All-Up
           8.2.5. Germany Proteomics Market All-Up
           8.2.6. France Proteomics Market All-Up
           8.2.7. Spain Proteomics Market All-Up
           8.2.8. Rest of Europe Proteomics Market All-Up
    8.3. Asia-Pacific Proteomics Market Revenue Forecast till 2027 
    (Option 3: As a part of the free 25% customization) 
           8.3.1. Asia-Pacific Proteomics Market by Product
                     8.3.1.1. Instruments
                     8.3.1.2. Reagents
                     8.3.1.3. Services
           8.3.2. Asia-Pacific Proteomics Market by Technology
                     8.3.2.1. Microarray
                     8.3.2.2. X-Ray Crystallography
                     8.3.2.3. Spectroscopy
                     8.3.2.4. Chromatography
                     8.3.2.5. Protein Fractionation Systems
                     8.3.2.6. Electrophoresis
                     8.3.2.7. Surface Plasma Resonance Systems
           8.3.3. Asia-Pacific Proteomics Market by Application
                     8.3.3.1. Drug Discovery
                     8.3.3.2. Disease Diagnosis
                     8.3.3.3. Others
           8.3.4. China Proteomics Market All-Up
           8.3.5. India Proteomics Market All-Up
           8.3.6. Japan Proteomics Market All-Up
           8.3.7. Rest of APAC Proteomics Market All-Up
    8.4. RoW Proteomics Market Revenue Forecast till 2027
    (Option 4: As a part of the free 25% customization)  
           8.4.1. RoW Proteomics Market by Product
                     8.4.1.1. Instruments
                     8.4.1.2. Reagents
                     8.4.1.3. Services
           8.4.2. North America Proteomics Market by Technology
                     8.4.2.1. Microarray
                     8.4.2.2. X-Ray Crystallography
                     8.4.2.3. Spectroscopy
                     8.4.2.4. Chromatography
                     8.4.2.5. Protein Fractionation Systems
                     8.4.2.6. Electrophoresis
                     8.4.2.7. Surface Plasma Resonance Systems
           8.4.3. North America Proteomics Market by Application
                     8.4.3.1. Drug Discovery
                     8.4.3.2. Disease Diagnosis
                     8.4.3.3. Others
           8.4.4. Brazil Proteomics Market All-Up
           8.4.5. South Africa Proteomics Market All-Up
           8.4.6. Saudi Arabia Proteomics Market All-Up
           8.4.7. UAE Proteomics Market All-Up
           8.4.8. Rest of world (remaining countries of the LAMEA region) Proteomics Market All-Up

9. Competitive Landscape Analysis
    9.1. Porter’s Five Forces Analysis
    9.2. Industry – Competitive Landscape
    9.3. Market Presence (Intensity Mapping)
    9.4. Key Strategic Market Developments 

10. Company Profiles (Option 5: Free 25% Customization - Profiles of 5 Additional Companies of your Choice)
    10.1. Illumina, Inc.
           10.1.1. Company Overview    
           10.1.2. Key Executives 
           10.1.3. Footprint & Employee Strength 
           10.1.4. Product Offerings    
           10.1.5. Financials
           10.1.6. Key Company Developments 
    10.2. Agilent Technologies, Inc.
           10.2.1. Company Overview    
           10.2.2. Key Executives   
           10.2.3. Footprint & Employee Strength
           10.2.4. Product Offerings
           10.2.5. Financials
           10.2.6. Key Company Developments
    10.3. Bio-Rad Laboratories, Inc.
           10.3.1. Company Overview    
           10.3.2. Key Executives
           10.3.3. Footprint & Employee Strength
           10.3.4. Product Offerings
           10.3.5. Financials
           10.3.6. Key Company Developments
    10.4. APPLIED BIOMICS, INC.
           10.4.1. Company Overview    
           10.4.2. Key Executives
           10.4.3. Footprint & Employee Strength
           10.4.4. Product Offerings
           10.4.5. Financials
           10.4.6. Key Company Developments
    10.5. Thermo Fisher Scientific, Inc.
           10.5.1. Company Overview    
           10.5.2. Key Executives   
           10.5.3. Footprint & Employee Strength
           10.5.4. Product Offerings
           10.5.5. Financials
           10.5.6. Key Company Developments
    10.6. Sigma-Aldrich Co.
           10.6.1. Company Overview    
           10.6.2. Key Executives
           10.6.3. Footprint & Employee Strength
           10.6.4. Product Offerings
           10.6.5. Financials
           10.6.6. Key Company Developments
    10.7. F. Hoffmann-La Roche Ltd.
           10.7.1. Company Overview
           10.7.2. Key Executives
           10.7.3. Footprint & Employee Strength
           10.7.4. Product Offerings
           10.7.5. Financials
           10.7.6. Key Company Developments    
    10.8. PerkinElmer Inc.
           10.8.1. Company Overview
           10.8.2. Key Executives 
           10.8.3. Footprint & Employee Strength
           10.8.4. Product Offerings
           10.8.5. Financials
           10.8.6. Key Company Developments    
    10.9. Luminex Corporation
           10.9.1. Company Overview
           10.9.2. Key Executives 
           10.9.3. Footprint & Employee Strength
           10.9.4. Product Offerings
           10.9.5. Financials
           10.9.6. Key Company Developments   
    10.10. Promega Corporation
           10.10.1. Company Overview
           10.10.2. Key Executives 
           10.10.3. Footprint & Employee Strength
           10.10.4. Product Offerings
           10.10.5. Financials
           10.10.6. Key Company Developments   

11. About GMI Research

*Details on Financials might not be available in case of unlisted/private companies.

*The list of companies is based on preliminary research in this sample report, the companies in the final report may change based on research findings.